Gabelli Healthcare & WellnessRx Trust (GRX) reported that its 10% owner, Saba Capital Management, L.P., indirectly purchased 519 common shares on September 30, 2026, at $9.52 per share. The reported indirect position following the purchase was 2,156,552 shares. The Rule 10b5-1 checkbox was unchecked.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider filing showing that Saba Capital Management, L.P., a ten percent owner, purchased 400 shares of Common Stock on September 11, 2026 in an open-market or private transaction at $9.71 per share, bringing its indirect holdings to 2,156,033 shares.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that major shareholder Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026, at $10.08 per share in an open-market or private transaction, held indirectly. Following this trade, Saba Capital’s reported indirect holdings rose to 2,155,633 shares. No Rule 10b5-1 trading plan is reported for this transaction.
Gabelli Healthcare & WellnessRx Trust (GRX) received an amended Schedule 13D (Amendment No. 4) reporting that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the reporting persons) beneficially own 2,155,133 common shares of GRX. This represents 14.32% of GRX’s common shares, based on 15,050,683 shares outstanding as of 12/31/25 as disclosed in GRX’s N-CSR filed 3/9/26. The reporting persons hold shared voting and shared dispositive power over all of these shares and no sole power. Approximately $20,771,553 in aggregate was paid to acquire the reported shares, funded by investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All transactions in the past 60 days before August 27, 2026 were executed in the open market and are detailed in an attached schedule.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 4,340 shares of common stock on August 27, 2026, in an open-market or private transaction at $10.05 per share. Following this indirect ownership purchase, Saba Capital Management reports holding 2,155,133 common shares of GRX.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 7,087 shares of Common Stock in an open-market or private transaction on 2026-08-21 at $10.13 per share. After this transaction, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of GRX Common Stock.
Gabelli Healthcare & WellnessRx Trust (GRX) had a Form 4 filed reporting that Saba Capital Management, L.P., a ten percent owner, purchased 24,102 shares of GRX common stock on 2026-08-19 at $10.13 per share in an open-market or private transaction. Following this buy, Saba’s indirectly held position is reported as 2,143,706 shares. The Rule 10b5-1 checkbox was not marked, indicating the trade was not reported as pursuant to a pre-arranged trading plan.
Gabelli Healthcare & WellnessRx Trust reported that Christopher J. Jackson, who serves as Secretary, filed an initial statement of beneficial ownership of securities. The filing does not list any reportable transactions or holdings, indicating this is an administrative Form 3 establishing his insider reporting status.
Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of common stock. On 2026-08-14 it bought 1,203 shares at $9.86 per share in an open market or private transaction, bringing its reported indirect holdings to 2,119,604 shares.